chr17-219662-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006987.4(RPH3AL):c.688G>T(p.Val230Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,680 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006987.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPH3AL | NM_006987.4 | c.688G>T | p.Val230Phe | missense_variant | 8/10 | ENST00000331302.12 | NP_008918.1 | |
RPH3AL | NM_001190411.2 | c.688G>T | p.Val230Phe | missense_variant | 7/9 | NP_001177340.1 | ||
RPH3AL | NM_001190412.2 | c.601G>T | p.Val201Phe | missense_variant | 7/9 | NP_001177341.1 | ||
RPH3AL | NM_001190413.2 | c.601G>T | p.Val201Phe | missense_variant | 6/8 | NP_001177342.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPH3AL | ENST00000331302.12 | c.688G>T | p.Val230Phe | missense_variant | 8/10 | 2 | NM_006987.4 | ENSP00000328977 | P1 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461680Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727148
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.688G>T (p.V230F) alteration is located in exon 8 (coding exon 6) of the RPH3AL gene. This alteration results from a G to T substitution at nucleotide position 688, causing the valine (V) at amino acid position 230 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at